Is Osteoporosis Curable? Insights from Rosedale, MD Rheumatologists

Bone density, commonly measured by a DEXA scan and expressed as a T-score, reflects the strength and health of your bones. When bone density decreases, as seen in conditions like osteoporosis or osteopenia, the risk of fractures rises significantly. At Jean Walter Infusion Center, we specialize in advanced therapies for patients with low bone density, helping to reduce fracture risk and improve quality of life.

Comprehensive Treatment Options
Our center offers a range of evidence-based treatments for osteoporosis and related conditions, including intravenous (IV) medications such as denosumab. These infusion therapies are particularly beneficial for patients who cannot tolerate oral medications, have gastrointestinal issues, or require more intensive treatment. 

Calcium and vitamin D supplementation, along with weight-bearing exercise, are also integral parts of our patients’ individualized care plans.

Realistic Goals and Ongoing Support
While these interventions can slow bone loss, increase bone density, and lower fracture risk, fully restoring bone density to “normal” levels is uncommon—especially in older adults or those with long-standing osteoporosis. Most treatments, including the infusion therapies delivered at Jean Walter Infusion Center, focus on stabilizing or modestly increasing bone mass and improving bone quality. Even anabolic agents, which can stimulate new bone formation, rarely return bone density to the levels seen in healthy young adults.

Importantly, even modest improvements in bone density—or simply preventing further loss—can significantly reduce the risk of fractures. That’s why our primary treatment goal is to prevent fractures and maintain your independence, rather than to restore bone density to a specific reference range.

Personalized Care and Monitoring
Your bone health is influenced by factors such as age, medical history, duration of bone loss, and your individual response to therapy. At Jean Walter Infusion Center, we emphasize regular monitoring with DEXA scans and lab tests, and we tailor each treatment plan to your specific needs. Our experienced infusion nurses and medical team are committed to supporting you at every step, ensuring you receive safe, effective, and compassionate care.

At Jean Walter Infusion Center, we are dedicated to helping our patients achieve the best possible outcomes with therapies aimed at improving bone density, including intravenous and injectable options such as bisphosphonates, denosumab, and anabolic agents like teriparatide. After initiating these treatments, it’s important to understand the expected timeline for measurable changes in bone mineral density (BMD).

When Will You See Results?
Significant improvements in BMD, as measured by dual-energy X-ray absorptiometry (DEXA) scans, are usually observed after 6 to 12 months of consistent therapy. The degree and speed of improvement depend on the specific medication used, the area of bone measured, patient adherence, baseline bone density, age, sex, and overall health.

At Jean Walter Infusion Center, we most commonly see meaningful increases in BMD at the lumbar spine and hip regions after about one year of therapy. Some patients, particularly those receiving anabolic therapies, may see changes a bit sooner.

Why Regular Monitoring Matters
While certain blood tests can show changes in bone metabolism within weeks to months, these markers do not directly indicate increased bone density. At our center, we use these tests as useful adjuncts, but the most reliable measure of therapy success remains repeat DEXA scans.

At Jean Walter Infusion Center, we provide access to the most advanced, FDA-approved medical interventions for osteoporosis. Under the supervision of Dr. Nasseri, MD, our Rosedale facility offers high-impact therapies that surpass the efficacy of traditional oral medications, particularly for patients with absorption issues or severe bone loss.

The cornerstone of our bone-health program includes:

• Reclast (Zoledronic Acid): A powerful IV bisphosphonate typically administered once a year. It is highly effective at increasing bone mineral density and significantly reducing the risk of hip and spinal fractures.
• Prolia (Denosumab): A specialized monoclonal antibody (RANK ligand inhibitor) administered as a subcutaneous injection every six months. It targets the specific biological pathway responsible for bone breakdown.
• Evenity (Romosozumab): A dual-acting bone-forming agent that both increases bone formation and reduces bone resorption, often used for those at very high risk of fracture.

By choosing infusion therapy at Jean Walter Infusion Center, patients benefit from 100% medication absorption and the clinical expertise of Dr. Nasseri, MD. This approach ensures that your skeletal system receives the full dose required to rebuild density and protect your long-term mobility in a safe, monitored environment.

At Jean Walter Infusion Center, our experienced clinical team works closely with referring rheumatologists and other specialists to monitor the success of osteoporosis treatment through a comprehensive approach combining clinical assessments, laboratory testing, and advanced diagnostic imaging.

Bone Mineral Density (BMD) Monitoring:
One of the primary methods for evaluating osteoporosis treatment effectiveness is the bone mineral density (BMD) test, typically performed using dual-energy X-ray absorptiometry (DEXA) scans. At Jean Walter Infusion Center, we coordinate with your healthcare provider to ensure DEXA scans are completed at baseline and then repeated every one to two years. This regular monitoring enables us to track changes in bone density over time and to assess whether your prescribed therapies are helping to maintain or improve bone strength.

Clinical Assessments and Ongoing Monitoring:
Our clinicians are vigilant in evaluating patients for any new fractures or bone pain during infusion visits. If a patient experiences a fracture or persistent bone pain while on therapy, this may indicate the need to modify the treatment plan. Regular assessments, including posture, height, and mobility checks, are part of our commitment to early detection of potential complications, such as vertebral fractures.

Laboratory Testing:
Jean Walter Infusion Center offers convenient on-site laboratory services for patients receiving osteoporosis therapy. Routine blood tests can assess calcium and vitamin D levels, kidney function, and markers of bone turnover. These measurements provide valuable information about your response to treatment and help us detect any potential complications related to osteoporosis medications.

Comprehensive Patient Support:
Throughout your treatment journey, our team emphasizes the importance of medication adherence—especially for those receiving intravenous osteoporosis therapies at our center—as well as lifestyle modifications and fall prevention strategies. We engage each patient in ongoing discussions about their progress, address any side effects or concerns, and collaborate with your referring provider to make any necessary adjustments to your treatment plan. Our goal is to optimize your bone health and reduce the risk of fractures.

At Jean Walter Infusion Center, Dr. Nasser Nasseri and his clinical experts specialize in turning the tide against bone degeneration for Rosedale residents. Moving beyond basic supplements, the center provides a personalized therapeutic roadmap utilizing sophisticated biologics and bone-building infusions such as Reclast, Prolia, and Evenity. These treatments are meticulously selected based on your specific diagnostic data to either inhibit bone resorption or stimulate new bone growth. By partnering with Dr. Nasseri, patients receive high-level rheumatology expertise and compassionate care dedicated to strengthening their bones and improving their overall quality of life.

If you are receiving osteoporosis therapy or have questions about your treatment, the team at Jean Walter Infusion Center is here to support you every step of the way. For more information, contact us today or book an appointment online now! We are conveniently located at 9114 Philadelphia Rd, Suite 208A, Rosedale, MD 21237. We serve patients from Rosedale MD, Parkville MD, Middle River MD, Rossville MD, Overlea MD, and surrounding areas.